Major Shareholders

Summary of Issued Securities 

Ordinary Shares
Issued shares at 18 July 2017	319,315,844
Employee options over ordinary shares at 18 July 2017	13,245,750

Major Shareholders 
The top 20 shareholders in Pharmaxis Ltd on 30 June 2017 are:

Name	Number Of Shares '000	% Total
1. Citicorp Nominees Pty Limited	88,922	28%
2. National Nominees Limited	38,137	12%
3. HSBC Custody Nomiees (Australia) Limited	26,931	8%
4. JP Morgan Nominees Australia Limited	15,362	5%
5. George Engineering Pty Ltd (PG Super Fund)	2,500	1%
6. Mr Yingkai Li	2,400	1%
7. David Newnham Super Pty Ltd	2,289	1%
8. Healthcare Management Consulting (Australia) Pty Ltd	2,220	1%
9. Mutual Trust Pty Ltd	2,185	1%
10. Pakasoluto Pty Limited (Barkl Family Super Fund A/C)	2,087	1%
11. Simgon Pty Ltd (RK Super A/C)	1,750	1%
12. Moggs Creek Pty Ltd (Moggs Creek Super A/C)	1,747	1%
13. Alpha Matilda Trading Pty Ltd	1,623	1%
14. Lawn Views Pty Ltd	1,253	0%
15. Mr Marco Andrea Negro	1,200	0%
16. Ginga Pty Ltd (TG Klinger S/F a/c)	1,159	0%
17. Mr Brian Tully & Mrs Margaret Tully	1,146	0%
18. Killcare Holdings Pty Ltd	1,104	0%
19. Ms Bei Xu + Mr Dongning Wu	1,081	0%
20. Capital Regional et Cooperatif Desjardins	1,054	0%

Note: the above tables are updated after each quarter end

Substantial Shareholders 
Pharmaxis has received the following substantial shareholder notices: 

Name	Percent	Date
BVF Partners LP	19.97%	30 August 2017
Australian Ethical Australian Share Fund	10.16%	3 April 2017
Allan Gray Australia	7.00%	29 August 2017
Montoya Investments Limited	6.20%	12 April 2013